Cargando…
Combining mTOR Inhibition with Radiation Improves Antitumor Activity in Bladder Cancer Cells In Vitro and In Vivo: A Novel Strategy for Treatment
PURPOSE: Radiation therapy for invasive bladder cancer allows for organ preservation but toxicity and local control remain problematic. As such, improving efficacy of treatment requires radiosensitization of tumor cells. The aim of study is to investigate if the mammalian Target of Rapamycin (mTOR),...
Autores principales: | Nassim, Roland, Mansure, Jose Joao, Chevalier, Simone, Cury, Fabio, Kassouf, Wassim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684614/ https://www.ncbi.nlm.nih.gov/pubmed/23799002 http://dx.doi.org/10.1371/journal.pone.0065257 |
Ejemplares similares
-
A Novel Mechanism of PPAR Gamma Induction via EGFR Signalling Constitutes Rational for Combination Therapy in Bladder Cancer
por: Mansure, Jose Joao, et al.
Publicado: (2013) -
Correction: A Novel Mechanism of PPAR Gamma Induction via EGFR Signalling Constitutes Rational for Combination Therapy in Bladder Cancer
por: Mansure, Jose Joao, et al.
Publicado: (2013) -
Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy
por: Marcq, Gautier, et al.
Publicado: (2022) -
Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer
por: Bachir, Bassel G., et al.
Publicado: (2017) -
Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer
por: Shinde-Jadhav, Surashri, et al.
Publicado: (2021)